Share Name Share Symbol Market Type Share ISIN Share Description
Oxford Biodyn LSE:OBD London Ordinary Share GB00BD5H8572 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.00p -0.95% 208.00p 208.00p 216.00p 208.00p 208.00p 208.00p 8,113 12:32:41
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 1.2 -4.0 -4.5 - 182.03

Oxford Biodyn Share Discussion Threads

Showing 76 to 98 of 100 messages
Chat Pages: 4  3  2  1
DateSubjectAuthorDiscuss
02/7/2018
12:11
Dr Alexandre Akoulitchev spoke with DT about their recent publication in EBioMedicine, more about the biomarkers and the next steps for their technology in the ALS field: INTERVIEW - http://bit.ly/2tGUBUr Written Q&A - http://bit.ly/2tLXP8W
astonedt
05/6/2018
19:39
Duly noted with thanks volsung.
saul goodman
05/6/2018
15:59
Who cares but you!
imperial3
04/6/2018
15:07
Sold the lot
volsung
18/5/2018
09:13
Hark I hear the advance of tumbleweeds
volsung
25/4/2018
15:11
get a grip of yer intangibles man
elpirata
25/4/2018
15:07
I fear it may be too late
volsung
25/4/2018
14:53
aye, any more of this nonsense & you'll go the way of muttlly
elpirata
25/4/2018
14:45
I am having a weird day elpirata. I seem to have fallen in love with the Diggles' stock. i'm sure it will end badly
volsung
25/4/2018
12:40
on a short for the avoidance of any doubt?
elpirata
25/4/2018
12:30
These look nice. I'm having some.
volsung
11/4/2018
15:30
Q&A also available - http://bit.ly/2uQFWsK
astonedt
11/4/2018
15:27
Director of Business Development & Head of Statistics Dr. Ewan Hunter discusses the publication of a paper in the Journal of Translational Medicine in this interview with DirectorsTalk. http://bit.ly/2GuM9vE
astonedt
21/3/2018
13:47
Chief Scientific Officer Dr Alexandre Akoulitchev discusses their latest ALS biomarker data with DirectorsTalk Interview - http://bit.ly/2u48nCO Q&A - http://bit.ly/2u6Tfor
astonedt
15/11/2017
13:34
It would be good to see them at Sharesoc or similar to meet a wider group of investors
shoee62
15/11/2017
11:58
I know which one of the two options I would rather have.
saul goodman
13/11/2017
07:57
Aparently the cancer risk from a single ct scan is the equivalent of smoking 700 cigarettes ...
catsick
07/11/2017
07:22
Interesting new deal, for me though the ability to identify and accurately gauge the growth of breast cancers is the home run for obd. 40pct of women in random autopsies are found to have cancers most too small to pick up on mammograms, if obd technology is better than a mammogram then it would seem they should have every woman in the world using their product/service
catsick
04/11/2017
14:41
It sounds to me like the reality for these guys is they are sat on something that in the us would be viewed as being worth gazzillions but in the uk there is no concept of the true value, I am suspecting this is being promoted as a potential dual listing in which case a much higher valuation will quickly materialize....
catsick
04/11/2017
07:57
I note that the share price is weakening a bit. Is there any news on the horizon?
mint1111
30/10/2017
09:21
Fair point Badger.
ph1ts
26/10/2017
20:49
How about a company that loses mio £2pa.............with a mkt cap of £230mio!!!!!
badger60
26/10/2017
11:06
Speak for yourself Badger. I think it could do very well. No volume at all to judge it on.
ph1ts
Chat Pages: 4  3  2  1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20180716 12:34:20